Related Experiment Video
Updated: Jan 1, 2026
Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
Published on: May 2, 2022
Renal Clearable Theranostic Nanoplatforms for Gastrointestinal Stromal Tumors
Homan Kang1, Wesley R Stiles1, Yoonji Baek1
1Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA.
Abstract:
Advances in molecular imaging modalities have accelerated the diagnosis and treatment of human diseases. However, tumors less than 1 cm in size still remain difficult to localize by conventional means because of the difficulty in specific targeting/delivery to the tumor site. Furthermore, high nonspecific uptake in the major organs and persistent background retention results in low tumor-to-background ratio. The targeting and therapy of gastrointestinal stromal tumors (GIST) using nonsticky and renal clearable theranostic nanoparticles (a.k.a. H-Dots) are demonstrated. H-Dots not only target GIST for image-guided surgery, but also tailor the fate of anticancer drugs such as imatinib (IM) to the tumor site resulting in efficient treatment of unresectable GIST. In addition, H-Dots can monitor targetability, pharmacokinetics, and drug delivery, while also showing therapeutic efficacy in GIST-bearing xenograft mice following surgical resection. More importantly, IM loaded H-Dots exhibit lower uptake into the immune system, improved tumor selectivity, and increased tumor suppression compared to free IM, which accumulates in the spleen/liver. Precisely designed H-Dots can be used as a promising theranostic nanoplatform that can potentially reduce the side effects of conventional chemotherapies.
Insights
New theranostic nanoparticles called H-Dots effectively target and treat small gastrointestinal stromal tumors (GIST). These nanoparticles improve drug delivery, reduce side effects, and enhance imaging for better surgical guidance.
Area of Science:
- Nanotechnology
- Molecular Imaging
- Oncology
Background:
- Small tumors (<1 cm) are challenging to localize with current molecular imaging.
- High nonspecific organ uptake and background retention limit tumor-to-background ratios.
- Gastrointestinal stromal tumors (GIST) require improved diagnostic and therapeutic strategies.
Purpose of the Study:
- To demonstrate the efficacy of H-Dots as theranostic nanoparticles for GIST.
- To evaluate H-Dots for image-guided surgery and targeted anticancer drug delivery.
- To assess the potential of H-Dots to reduce chemotherapy side effects.
Main Methods:
- Development and application of nonsticky, renal clearable theranostic nanoparticles (H-Dots).
- Targeting GIST in xenograft mouse models.
- Loading nanoparticles with imatinib (IM) for targeted drug delivery.
- Monitoring of targetability, pharmacokinetics, and drug delivery.
Main Results:
- H-Dots successfully targeted GIST, enabling image-guided surgery.
- IM-loaded H-Dots demonstrated efficient treatment of unresectable GIST.
- H-Dots showed therapeutic efficacy in GIST-bearing xenograft mice post-surgery.
- IM-loaded H-Dots exhibited lower immune system uptake and improved tumor selectivity compared to free IM.
Conclusions:
- H-Dots represent a promising theranostic nanoplatform for GIST.
- This platform facilitates targeted drug delivery and reduces systemic toxicity.
- H-Dots have the potential to minimize side effects associated with conventional chemotherapy.
